Australian Aerospace & Defense Stock News

ASX:EUR
ASX:EURMetals and Mining

European Lithium (ASX:EUR) Valuation in Focus After Share Buy-Back and Critical Metals Stake Sale

European Lithium (ASX:EUR) is making headlines after launching a share buy-back and selling part of its holding in Critical Metals Corp. These steps have raised substantial capital. Investors are watching how these moves impact the company’s future direction. See our latest analysis for European Lithium. These capital moves come on the heels of a remarkable turnaround in sentiment. The last month’s share price return of 202% and year-to-date return of 644% have captured investor attention...
ASX:VNT
ASX:VNTConstruction

A$935 Million Defence Contract Might Change The Case For Investing In Ventia Services Group (ASX:VNT)

Ventia Services Group announced it has secured a new contract valued at approximately A$935 million to provide service and support for the Australian Defence Force’s clothing capability, commencing May 2026 for an initial term of seven years with extension options. This agreement appoints Ventia as the sole industry partner, enhancing its role in Defence supply chains and reinforcing its expertise in long-term government contracting. We’ll explore how this Defence contract win supports...
ASX:MGX
ASX:MGXMetals and Mining

IPD Group And 2 Other ASX Penny Stocks To Consider

The Australian market is facing a potential decline, influenced by the rising gold prices and weaker-than-expected jobs data, which could keep the indices within the 9,000 range. Amid these conditions, investors often look for opportunities that balance risk and reward, making penny stocks an intriguing option. Although considered a vintage term, penny stocks can still offer significant value when backed by robust financials and solid fundamentals.
ASX:PNV
ASX:PNVMedical Equipment

PolyNovo (ASX:PNV) Valuation in Focus After Board Appointment of ResMed Veteran Robert Douglas

PolyNovo (ASX:PNV) has just appointed Robert Douglas to its Board of Directors, sparking fresh interest from investors. Douglas’s background in medical device technology and board-level oversight could influence PolyNovo’s next phase of growth. See our latest analysis for PolyNovo. PolyNovo’s appointment of Robert Douglas arrives at a time when the market has been recalibrating its expectations. The stock’s 1-year total shareholder return of -45.5% and year-to-date share price return of...